MedPath

The comparative evaluation of ibuprofen & gabapantin on postendodontic pain.

Phase 2
Conditions
Accute irreversible pulpit.
Pulpitis
Registration Number
IRCT201205069564N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

age more than 15 years old; pian level moderate to sever(VAS more than 40mm) and clinical diagnosis reffering ireversible accute pulpitis on inferior first molar.
Exclusion criteria: antibiotic therapy one week before the study; analgesia therapy 6 hours before intervention; history of mental desease, epilepsy; consumption of any epilepsy drug and history of systemic desease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: 1 hour pre operation, hourly till 6 hours and 12, 24 and 48 hours after operation. Method of measurement: VAS.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: Up to 2 days post treatment. Method of measurement: Question form.;Evaluation of drug efficacy. Timepoint: Up to 2days post treatment. Method of measurement: Question form.
© Copyright 2025. All Rights Reserved by MedPath